Literature DB >> 22004891

Eupatorium perfoliatum L.: phytochemistry, traditional use and current applications.

Andreas Hensel1, Mareike Maas, Jandirk Sendker, Matthias Lechtenberg, Frank Petereit, Alexandra Deters, Thomas Schmidt, Timo Stark.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Eupatorium perfoliatum L. originates from North America, where it has been widely used since centuries by native Indians. Additionally extracts are used also in Europe as immunostimulating agent for treatment of fever and cold. The following review summarizes published data on phytochemistry, ethnopharmacological use, as well as clinical and preclinical data.
MATERIALS AND METHODS: Literature survey was performed via SciFinder(®) on papers and patents and by systematic research in ethnopharmacological literature at various university libraries.
RESULTS: The phytochemical composition of Eupatorium perfoliatum is described in detail for volatile oil, caffeic acid derivatives, flavonoids, sesquiterpene lactones, tannins, polysaccharides. Methods for analytical quality control, as well as specification for relevant lead structures can be deduced from published batch analysis. Preclinical studies indicate anti-inflammatory effects of ethanolic extracts, which can be correlated on a molecular level to eupafolin and sesquiterpen lactones. Antiplasmodial, antioxidative and immunomodulating activities are additionally discussed. Clinical data on the use of Eupatorium perfoliatum do not meet modern GCP requirements, but do indicate positive tendencies for use of ethanolic extracts for treatment of common colds.
CONCLUSION: While the postulated immunostimulating properties of Eupatorium perfoliatum have not been confirmed by in vitro data, animal-studies and in vitro experiments with plant extracts both indicate antiinflammatory effects beside antiplasmodial effect against Plasmodium falciparum. Such an antiinflammation caused by the ethanolic extracts can be correlated well with clinical symptoms related to diseases as common cold, rheumatism, athritis etc. These data also support the plausibility of the plant's traditional use by the North American indigenous population and early European settlers. In principle quality aspects of the herbal material have to be affirmed by establishing modern pharmacopoeial control methods to guarantee constant and reliable quality.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22004891     DOI: 10.1016/j.jep.2011.10.002

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  7 in total

1.  Untargeted LC-MS metabolomic studies of Asteraceae species to discover inhibitors of Leishmania major dihydroorotate dehydrogenase.

Authors:  Lucas A Chibli; Annylory L Rosa; Maria Cristina Nonato; Fernando B Da Costa
Journal:  Metabolomics       Date:  2019-04-04       Impact factor: 4.290

2.  Eupafolin suppresses prostate cancer by targeting phosphatidylinositol 3-kinase-mediated Akt signaling.

Authors:  Kangdong Liu; Chanmi Park; Hanyong Chen; Joonsung Hwang; N R Thimmegowda; Eun Young Bae; Ki Won Lee; Hong-Gyum Kim; Haidan Liu; Nak Kyun Soung; Cong Peng; Jae Hyuk Jang; Kyoon Eon Kim; Jong Seog Ahn; Ann M Bode; Ziming Dong; Bo Yeon Kim; Zigang Dong
Journal:  Mol Carcinog       Date:  2014-04-04       Impact factor: 4.784

3.  Eupafolin and Ethyl Acetate Fraction of Kalanchoe gracilis Stem Extract Show Potent Antiviral Activities against Enterovirus 71 and Coxsackievirus A16.

Authors:  Ching-Ying Wang; Shun-Chueh Huang; Zhen-Rung Lai; Yu-Ling Ho; Yu-Jen Jou; Szu-Hao Kung; Yongjun Zhang; Yuan-Shiun Chang; Cheng-Wen Lin
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-02       Impact factor: 2.629

4.  The Anti-Inflammatory Effects and Mechanisms of Eupafolin in Lipopolysaccharide-Induced Inflammatory Responses in RAW264.7 Macrophages.

Authors:  Chin-Chaun Chen; Ming-Wei Lin; Chan-Jung Liang; Shu-Huei Wang
Journal:  PLoS One       Date:  2016-07-14       Impact factor: 3.240

5.  Eupafolin enhances TRAIL-mediated apoptosis through cathepsin S-induced down-regulation of Mcl-1 expression and AMPK-mediated Bim up-regulation in renal carcinoma Caki cells.

Authors:  Min Ae Han; Kyoung-Jin Min; Seon Min Woo; Bo Ram Seo; Taeg Kyu Kwon
Journal:  Oncotarget       Date:  2016-10-04

6.  Eupafolin ameliorates lipopolysaccharide-induced cardiomyocyte autophagy via PI3K/AKT/mTOR signaling pathway.

Authors:  Yan Gao; Yi Zhang; Yangyang Fan
Journal:  Iran J Basic Med Sci       Date:  2019-11       Impact factor: 2.699

7.  Eupafolin alleviates cerebral ischemia/reperfusion injury in rats via blocking the TLR4/NF‑κB signaling pathway.

Authors:  Xingwang Chen; Zhijun Yao; Xian Peng; Long Wu; Huachu Wu; Yuantong Ou; Jianbo Lai
Journal:  Mol Med Rep       Date:  2020-10-26       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.